Company profile · Warsaw, Poland

BioResearch Pharma S.A.

Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs · Drug-repositioning R&D

Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis.

Lead
Lukasz Zybaczynski (verified ↗)
Address
ul. Zygmunta Glogera 2/11, 02-051 Warsaw, Poland (source ↗)
Compliance
Not yet on record
Last reviewed
24 Apr 2026 (1mo ago)
Scale
Drug-repositioning R&D
Capabilities
Drug Repositioning Pipeline · Dermatology Clinical Development · Clinical and Licensing Strategy
Founded
2014
Headcount
1-10
Site and address
Clinical profileSTATUS: VERIFIED APRIL 2026

Lukasz Zybaczynski

Chief Executive Officer and Co-Founder

Check official leadership source
Full addressul. Zygmunta Glogera 2/11, 02-051 Warsaw, Poland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source

EMIS company profile listing BioResearch Pharma at Zygmunta Glogera 2/11 in Warsaw.

Open source
Operating profile

Drug-repositioning R&D

Warsaw, Poland. Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs. Review completed on 24 Apr 2026.

2026 technical specializationDrug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs
Core capabilities
Drug Repositioning PipelineDermatology Clinical DevelopmentClinical and Licensing Strategy
Governance

Polish Office for Registration of Medicinal Products and EMA for future oversight

Public CEO disclosure, BioInMed member recognition, BioForum 2024 keynote documentation

Editorial note

Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs

Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis.

Editorial note

BioResearch Pharma is a Warsaw drug-repositioning biotech with a named CEO and public BioForum keynote visibility, focused on dermatology programs for alopecia and psoriasis.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026Last reviewed: 24 April 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Drug Repositioning Pipeline
Dermatology Clinical Development
Clinical and Licensing Strategy
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceBioResearch Pharma company news naming Lukasz Zybaczynski as CEO and Co-founder.Source origin: bioresearchpharma.comOpen source
Supporting evidenceBioResearch Pharma investors and media page.Source origin: bioresearchpharma.comOpen source
Physical-site evidenceEMIS company profile listing BioResearch Pharma at Zygmunta Glogera 2/11 in Warsaw.Source origin: emis.comOpen source
Infrastructure

Declared infrastructure

Drug-repositioning workflow
Preclinical dermatology models
Clinical development infrastructure
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is BioResearch Pharma S.A. located?
BioResearch Pharma S.A. operates from ul. Zygmunta Glogera 2/11, 02-051 Warsaw, Poland, Warsaw, Poland.
Who runs BioResearch Pharma S.A.?
BioResearch Pharma S.A. is led by Lukasz Zybaczynski, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
What does BioResearch Pharma S.A. do?
Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis. Core capabilities: Drug Repositioning Pipeline, Dermatology Clinical Development, Clinical and Licensing Strategy.
Editorial context

Related technical briefs

Briefs that name Warsaw as a covered market or city.